Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
China · Delayed Price · Currency is CNY 4.630
+0.070 (1.54%)
Feb 4, 2026, 3:00 PM CST
Lionco Pharmaceutical Group Company Description
Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China.
It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, and other applications.
The company was founded in 2003 and is based in Shannan, China.
Lionco Pharmaceutical Group Co.,Ltd.
| Country | China |
| Founded | 2003 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 436 |
| CEO | Ling Ping Tao |
Contact Details
Address: No. 20, National Highway 349 Shannan, 856100 China | |
| Phone | 86 89 3783 0666 |
| Website | lingkang.com.cn |
Stock Details
| Ticker Symbol | 603669 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000022R8 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ling Ping Tao | GM and Chairman of the Board |
| Jun Ke Zhang | Accounting Supervisor and Financial Director |
| Shuang Xi Li | Deputy General Manager |
| Hong Sheng Wang | Deputy General Manager |
| Xiao Gang Tao | Deputy GM and Director |
| Li Ming Liu | Deputy GM and Director |
| Guo Ping Sui | Vice President and Board Secretary |